Form4insider filings, from the source

SEC Form 4 · accession 0001225208-19-003719

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kevin J. Ballinger
Officer — EVP & Pres, Interven Cardio
Period of report
Feb 22, 2019
Accepted (ET)
Feb 26, 2019 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 22, 2019M3,766$0.00A96,630D
Common StockF2Feb 22, 2019F1,718$40.52D94,912D
Common StockF1,F2Feb 23, 2019M3,679$0.00A98,591D
Common StockF2Feb 23, 2019F1,678$40.52D96,913D
Common StockF1,F2Feb 24, 2019M2,867$0.00A99,780D
Common StockF2Feb 24, 2019F1,308$40.52D98,472D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Deferred Stock UnitsF1,F3—Feb 22, 2019M3,766D—Feb 22, 2021Common Stock3,7667,532D
Deferred Stock UnitsF1,F4—Feb 23, 2019M3,679D—Feb 23, 2020Common Stock3,6793,679D
Deferred Stock UnitsF1,F5—Feb 24, 2019M2,867D—Feb 24, 2019Common Stock2,8670D

Explanation of responses